San Francisco, California-based 1Life Healthcare Inc. is a revenue-generating healthcare technology and management services company affiliated with One Medical Group that delivers medical services in-office and virtually.
Shanghai, China-based I-Mab said that it has priced its initial public offering of 7.41 million American Depositary Shares at $14.00 per ADS, within its previously estimated range of $12.00 to $15.00 per ADS.
The ADSs will begin trading on January 17, 2020 on the Nasdaq Global Market under the symbol...
I-Mab is a clinical stage biopharmaceutical company developing novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.